PDL BIOPHARMA, INC.·4/A

Apr 7, 8:47 AM ET

Imbrogno Edward 4/A

4/A · PDL BIOPHARMA, INC. · Filed Apr 7, 2020

Insider Transaction Report

Form 4/AAmended
Period: 2020-01-08
Imbrogno Edward
VP, Finance and CAO
Transactions
  • Award

    Common stock

    2020-01-08+292,208314,565 total
Footnotes (1)
  • [F1]The restricted stock units will vest as follows: (a) 40% of the shares subject to the award shall vest on the one year anniversary of the grant date and (b) 2.5% of the shares subject to the award shall vest monthly thereafter; provided that recipient's continuous service has not terminated prior to the applicable vesting date, subject to earlier vesting upon a change in control.

Documents

2 files
  • 4
    wf-form4a_158626364825403.xml

    FORM 4/A

  • EX-24

    POWER OF ATTORNEY /S/ NATHAN KRYSZAK, ATTORNEY-IN-FACT FOR EDWARD IMBROGNO